Pregnancy Women and Individual Oral Prophylaxis in the Control of Gingival Inflammation (PRE-IOP) (PRE-IOP)

March 16, 2026 updated by: Carrouel Florence, Claude Bernard University

Clinical Comparison of Two Sonic Electric Toothbrushes and Two Manual Toothbrushes, Used Under Normal Oral Hygiene Conditions, on the Reduction of Gingival Inflammation in Pregnant Women Aged 18 to 40: Randomized Clinical Trial

Gingivitis in pregnant women is a common inflammatory periodontal disease that appears from the third month of pregnancy with an overall prevalence of 35 to 100%. This condition is induced by oral biofilm and exacerbated by increased levels of sex steroid hormones characteristic of pregnancy. Strict bacterial plaque control with both professional and home oral hygiene is essential. Manual toothbrushes require a more specific manual technique for women, while sonic electric toothbrushes, due to their ease of use, might be an excellent for oral individual prophylaxis. Therefore, the question of which type of manual or electric toothbrush might be more effective in reducing gingival inflammation in pregnant women is still unresolved. In literature there are a large number of in vitro clinical studies on this topic, there are currently no clinical studies investigating this long-term clinical comparison.

In this context, this study is a randomized clinical trial consisting of a comparative evaluation between two manual and two sonic electric toothbrushes in the efficacy of the control of plaque in order to reduce gingivitis in women during the period of pregnancy.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nancy, France
        • Clinique Majorelle

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female, 18 to 40 years of age
  • 15-18 weeks pregnant
  • Acceptance of study terms and conditions
  • Signature of informed consent form

Exclusion Criteria:

  • Protected women
  • Stage II,III periodontal disease (i.e. PD ≥ 4 mm, and/or CAL ≥ 4 mm), generalized (>30% od sites)
  • History or treatment of periodontal disease
  • Current dental or orthodontic treatment
  • Fewer than 20 natural teeth, excluding third molars
  • Taking medication affecting the gums and/or oral mucosa
  • Regular use (more than once a week) of interdental brushes and/or dental floss and/or mouthwash
  • Removable prosthesis
  • Dental implants
  • Systemic disorder such as blood disorders, diabetes, and risk of endocarditis infections
  • Anticoagulant treatment
  • Inability to follow protocol or non-cooperation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group using sonic toothbrush
Patient will be asked to use a sonic toothbrush for 3 months
Brush teeth with the electric toothbrush daily during 3 months
Experimental: Group using hydrosonic toothbrush
Patient will be asked to use a hydrosonic toothbrush for 3 months
Brush teeth with the hydrosonic toothbrush daily during 3 months
Experimental: Group using manual toothbrush with 5460 strands
Patients will be asked to use a manual toothbrush with 5460 strands for 3 months
Brush teeth with the manual toothbrush daily during 3 months
Placebo Comparator: Group using manual toothbrush
Patients will be asked to use a manual toothbrush for 3 months
Brush teeth with the manual toothbrush daily during 3 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of gingival bleeding from baseline during woman pregnancy
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Change of gingival inflammation in pregnant woman using manual or electric toothbrushes in daily practice
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect on gingival bleeding
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Bleeding on Probing
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Effect on gingival inflammation
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
gingival index
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Effect on dental plaque
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
plaque index
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Effect on gingival attachment
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
clinical attachment loss
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Effect on Periodontal Pocket
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Periodontal Pocket Probing Depth
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
Customer Satisfaction Score
Time Frame: T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)
  • the minimum and maximum values: 1, 7
  • lower scores mean a worse outcome.
  • the minimum and maximum values: 1, 7
  • lower scores mean a worse outcome.
  • the minimum and maximum values: 1, 7
  • lower scores mean a worse outcome. The score range from 1 (minimum) to 7 (maximum). Lower score mean a worse outcome
T1 (Baseline), T2 (+ 1 month) and T3 (+ 3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

July 6, 2023

First Submitted That Met QC Criteria

July 6, 2023

First Posted (Actual)

July 14, 2023

Study Record Updates

Last Update Posted (Actual)

March 18, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnant Woman

Clinical Trials on Sonicare DiamondClean 9000 Philips®

Subscribe